Search

Displaying results 8561 - 8570 of 10000 in total
  1. Drug

    Epeleuton

    go.drugbank.com/drugs/DB18100
    Investigational

    Synonyms: 15(s)-hydroxy-(5z,8z,11z,13e,17z)-eicosapentaenoic acid ethyl esterCategories: Fatty Acids, Omega-3
  2. Drug

    TQS-168

    go.drugbank.com/drugs/DB18108
    Experimental

    Synonyms: 2-(4-Tert-butylphenyl)-1H-benzimidazoleCategories: Heterocyclic Compounds, 2-Ring
  3. Drug

    2'-deoxythioguanosine

    go.drugbank.com/drugs/DB18117
    Experimental

    Synonyms: 2-amino-9-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-6-mercaptopurine, 2'-deoxy-6-thioguanosineCategories: Heterocyclic Compounds, 2-Ring
  4. Drug

    EP-0042

    go.drugbank.com/drugs/DB18120
    Investigational

    Synonyms: 3H-IMIDAZO(4,5-B)PYRIDINE, 6-CHLORO-7-(4-((4-CHLOROPHENYL)METHYL)-1-PIPERAZINYL)-2-(1,3-DIMETHYL-1H-PYRAZOL-4-YL)-Salts: EP-0042 fumarate
  5. Drug

    Briquilimab

    go.drugbank.com/drugs/DB18136
    Investigational

    Briquilimab is a humanized aglycosylated IgG1 kappa monoclonal antibody targeting CD117 (cKit).

    Synonyms: IMMUNOGLOBULIN G1 (297-GLUTAMINE), ANTI-(HUMAN C-KIT RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL JSP191 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL JSP191 .KAPPA.-CHAIN, DIMER
  6. Drug

    ATX-01

    go.drugbank.com/drugs/DB18141
    Investigational

    ATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).

  7. Drug

    MTL-CEBPA

    go.drugbank.com/drugs/DB18143
    Investigational

    MTL-CEBPA is a SMARTICLES liposomal formulation of MTL-501, a small activating RNA (saRNA) oligonucleotide.

  8. Drug

    ESK981

    go.drugbank.com/drugs/DB18155
    Investigational

    Synonyms: 4h-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one, 2,5,6,11,12,13-hexahydro-2-methyl-11-(2-methylpropyl)-8-(2-pyrimidinylamino)-, 4-methylbenzenesulfonate (1:1)Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  9. Drug

    BRG01

    go.drugbank.com/drugs/DB18173
    Investigational

    BRG01 is a genetically modified autologous CAR-T cell therapy under investigation for the treatment of nasopharyngeal carcinoma.[L48111]

  10. Drug

    BNT111

    go.drugbank.com/drugs/DB18177
    Investigational

    It consists of a fixed combination of mRNA-encoded, tumor-associated antigens.